Experiment summary for ENCSR000DSA
doi:10.17989/ENCSR000DSA
Summary
- Status
- released
- Assay
- ChIP-seq (Control ChIP-seq)
- Control type
- input library
- Biosample summary
- Homo sapiens cardiac myoblast originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days, 5 ng/mL Fibroblast growth factor 2 for 9 days, 6 ng/mL Activin A for 9 days
- Biosample Type
- in vitro differentiated cells
- Replication type
- unreplicated
- Description
- Control ChIP-seq on human H7-hESC differentiated 9 days
- Treatments
- 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 9 days, 5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 9 days, 6 ng/mL Activin A (CHEBI:81351) for 9 days
- Nucleic acid type
- DNA
- Fragmentation methods
- see document
- Platform
- Illumina Genome Analyzer
Attribution
ENCODE2 project
- Lab
- John Stamatoyannopoulos, UW
- Award
- U54HG004592 (John Stamatoyannopoulos, UW)
- Project
- ENCODE
- External resources
- Date submitted
- June 25, 2011
- Date released
- February 16, 2012
- Reference Epigenome
- ENCSR472YCH
- Treatment Time Series
- ENCSR831IZS , ENCSR114LRH , ENCSR182ORV
- Submitter comment
- Replicate 1,1 of this experiment was previously attributed to biosample ENCBS297AAA but it has since been corrected to the current biosample. Please note that the biosample term has remain unchanged.
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Library |
|---|---|---|---|---|
| 1 | 1 | Homo sapiens female embryo cardiac myoblast in vitro differentiated cells originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days, 5 ng/mL Fibroblast growth factor 2 for 9 days, 6 ng/mL Activin A for 9 days | ENCBS303BHK | ENCLB710CLL |